spacer
home > pmps > winter 2003 > the countdown starts for implementing new child-resistant/senior-friendly blister packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Countdown Starts for Implementing New Child-Resistant/Senior-Friendly Blister Packaging

In August 2003, the Medicines & Healthcare Products Regulatory Agency (MHRA) announced that the Government had accepted its recommendations for the introduction of greater safety measures on certain non-reclosable blister-packed drugs. These recommendations were put forward following the tragic death of a toddler after he accidentally overdosed on iron tablets contained in a standard blister pack.

Following this, on the 1st October 2003 a new legal standard for drugs packaging came into force. This new legislation marked the first step in moving the pharmaceutical industry towards delivering safer versions of non-reclosable blister-packed drugs. The legislation introduces a child-resistance standard based on the BS8404 test, which requires blister packs to be both child-resistant and senior-friendly, ensuring that the addition of barriers for children do not prevent the elderly from accessing capsules. This new standard has now been introduced for paracetamol, aspirin and iron tablets (containing more than 24mg of iron per tablet).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jonathan Bobbett, Managing Director at Pill protect™

Jonathan Bobbett is the owner and Managing Director of Pill protectTM, which is part of Three Point Blue Ltd, the holding company for Jonathan's business interests. In addition to Pill protectTM, this includes Bobbett Design, a major branding and design consultancy that has been running for more than 15 years and Blueprint Management Ltd, a specialist print procurement and print management business.

spacer
Jonathan Bobbett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement